JPH10306028A - Drug for controlling intestinal function by lipid digestive absorbent inhibition - Google Patents

Drug for controlling intestinal function by lipid digestive absorbent inhibition

Info

Publication number
JPH10306028A
JPH10306028A JP9149819A JP14981997A JPH10306028A JP H10306028 A JPH10306028 A JP H10306028A JP 9149819 A JP9149819 A JP 9149819A JP 14981997 A JP14981997 A JP 14981997A JP H10306028 A JPH10306028 A JP H10306028A
Authority
JP
Japan
Prior art keywords
chitosan
bifidobacterium bifidum
intestinal
absorbent
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9149819A
Other languages
Japanese (ja)
Inventor
Koji Haraguchi
興治 原口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP9149819A priority Critical patent/JPH10306028A/en
Publication of JPH10306028A publication Critical patent/JPH10306028A/en
Pending legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To obtain the subject medicine capable of improving bad feces caused by chitosan by formulating a mixture between Bifidobacterium bifidum or intestinal useful fungi and chitosan having lipid digestive absorbent inhibitory activity as an active ingredient. SOLUTION: This medicine contains a mixture between chitosan and Bifidobacterium bifidum or intestinal useful fungi as an active ingredient. As the Bifidobacterium bifidum, live Bifidobacterium bifidum is utilized. Further, in order to more enhance the effect, vegetable Plantago asiatica L. and apple fibers plus oligosaccarides are preferably added By this process, the objective drug for controlling intestinal function capable of being expected effects, for example, absorptive control for diet lipids, getting rid of constipation by means of multiplication of intestinal useful fungi, e.g. Bifidobacterium bifidum and the like, suppression for generation of large bowel cancer, prevention for obesity and lowering of cholesterol in blood is obtained.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、食餌脂質の吸収抑
制、ビフィズス菌等腸内有用菌増殖による便秘の解消、
大腸ガンの発生抑制、肥満防止、血中コレステロールの
低下などの作用を期待できる脂質消化吸収阻害整腸剤に
関するものである。
TECHNICAL FIELD The present invention relates to suppression of dietary lipid absorption, elimination of constipation due to growth of useful intestinal bacteria such as bifidobacteria,
The present invention relates to a lipid digestion-absorption-inhibiting intestinal preparation that can be expected to have effects such as suppression of the occurrence of colorectal cancer, prevention of obesity, and reduction of blood cholesterol.

【0002】[0002]

【従来の技術】厚生省は、成人病の名称を「生活習慣
病」と変え、子供の時からの健康づくり、治療より予防
のより重視を打ち出した。死因の約六割を占めるガン、
心臓病、脳血管障害等は食事などの生活習慣と深く関連
しており、中でも緊急課題なのが急速に増加している失
明や腎不全など合併症が深刻な問題となっている糖尿病
である。その危険因子の一つに肥満がある。その原因と
して食生活の変容、飽食による特に脂肪分の摂取過多が
指摘され、医薬品による食欲抑制剤や、摂取脂質の吸着
→消化管での吸収阻害→体外排出作用で注目されている
キトサンがある。
2. Description of the Related Art The Ministry of Health and Welfare has changed the name of adult disease to "lifestyle-related disease" and has put more emphasis on prevention than on health promotion and treatment since childhood. Cancer, which accounts for about 60% of the causes of death,
Heart disease, cerebrovascular disorder, and the like are deeply related to lifestyle such as diet, and the most urgent issue is diabetes in which complications such as blindness and renal failure, which are rapidly increasing, are serious problems. Obesity is one of the risk factors. Changes in dietary habits and excessive intake of fat due to satiation have been pointed out as causes, and appetite suppressants by drugs and chitosan, which is attracting attention due to absorption of ingested lipids → inhibition of absorption in the digestive tract → excretion from the body .

【0003】食欲抑制剤や脂肪蓄積阻害剤等の薬物は、
一般人に扱えるものでなく、しかもおお吐やホルモン系
バランスの乱れ等の副作用が指摘され医師の厳重な監視
が必要である。
[0003] Drugs such as appetite suppressants and fat accumulation inhibitors are
It is not something that can be handled by ordinary people, and side effects such as vomiting and hormonal imbalance are pointed out and strict monitoring by a doctor is required.

【0004】バイオマスであるキトサンは、文部省の助
成による公的機関や大学、先端企業等による研究報告か
ら生体親和性が抜群で安全性が極めて高く、脂質の消化
吸収阻害、血中コレステロールの低下、腫瘍の転移抑制
効果等が確認されている。しかし、肥満予防を目的とす
るキトサン多量摂取は大変効果的である反面「便秘」等
便性不良を引き起こす欠点も抱えており、利用者は原因
不明のまま脂質消化吸収抑制や痩身効果等への期待と便
性不良の峡で悩んでいる人もいるのが現実である。
[0004] Chitosan, which is biomass, has excellent biocompatibility and is extremely safe from research reports by public institutions, universities, and advanced companies with the support of the Ministry of Education, and inhibits digestion and absorption of lipids, lowers blood cholesterol, The effect of inhibiting metastasis of the tumor has been confirmed. However, while ingestion of chitosan in large amounts for the purpose of preventing obesity is very effective, it also has disadvantages such as "constipation", which causes inconvenience, and users can reduce lipid digestion absorption and slimming effects without knowing the cause. The reality is that some people are worried about the gorge of poor expectations and convenience.

【0005】[0005]

【発明が解決しようとする課題】一つの問題解決のた
め、新たな問題を誘発するようなミクロ的処方であって
は「全てが一つ」に集約される人間そのものの健康と美
容の維持にとって、いいもの、優しいものであるとは言
えない。
In order to solve one problem, microscopic prescriptions that induce new problems are not integrated into "all ones" but are necessary for maintaining the health and beauty of human beings. Not good, kind.

【0006】本発明は、成人病といわれた生活習慣病の
原因の中で、最も深刻化している糖尿病、肥満等の予防
として、脂質消化吸収阻害に大変効果があるキトサンの
摂取が引き起こすマイナス点便性不良の改善を目的とす
る脂質消化吸収阻害整腸剤を提供しようとするものであ
る。
[0006] The present invention is intended to prevent diabetes and obesity, which are the most serious of the lifestyle-related diseases referred to as adult diseases. It is an object of the present invention to provide a lipid digestion / absorption-inhibiting intestinal for the purpose of improving poor stool.

【0007】[0007]

【課題を解決するための手段】上記目的を達成する手段
として、原因おざなりのまま短絡的に下剤等を処方する
のは極めて危険である。新たな弊害を生み出す要因にな
るからである。
As means for achieving the above object, it is extremely dangerous to prescribe a laxative or the like in a short-circuit manner while keeping the cause. This is because it is a factor that creates new adverse effects.

【0008】本発明者は、バイオマスであるキチンおよ
びキトサン素材を日本市場における健康食品として商品
化した先駆けである。長年の愛用者サイドにおける情報
の収集から、人により便秘や逆にベタ便を起こす時があ
ることを見出していた。結果には必ず原因がある。注目
している内、摂取の仕方や年齢、体調、ストレス、生活
環境等の諸条件により発生することを発見した。
The inventor is a pioneer in commercializing biomass chitin and chitosan materials as health foods in the Japanese market. For many years, gathering information from the patrons' side has found that sometimes people have constipation or vice versa. The results always have a cause. While paying attention, it was discovered that it occurs due to various conditions such as the way of ingestion, age, physical condition, stress, living environment and the like.

【0009】原因物質は明らかにキトサンである。しか
し、セルロースと同様の食物繊維であるのに何故なのか
どうしても疑問を解明出来ない。毎日、便を観察する内
ある先入観に捕らわれ重大な事実をパスしていたことに
気がつき強い衝撃を受けた。色、形、臭い、その他、正
に腸内叢菌のアンバランスに他ならない。免疫作用を強
めるキトサン。菌の増殖を阻むキトサン。しかし「一般
細菌の成育を阻止するが、乳酸菌等有用菌にはほとんど
影響しない。」という部分を鵜呑み信じて疑わなかった
ところに落し穴があった。緑膿菌、枯草菌やブドウ球菌
のような病原性・非病原性細菌類の成育を阻止するキト
サンである。ボーダーライン以下の状況下においてはビ
フィズス菌等脳内有用菌さえも成育が阻止され減少、腸
内環境が悪化するのは至極当然なのである。
The causative agent is clearly chitosan. However, it is impossible to clarify why it is a dietary fiber similar to cellulose. Every day, I was shocked to notice that I was passing on serious facts as I was caught by a prejudice when observing the stool. It is nothing but color, shape, smell and other imbalances of intestinal flora. Chitosan that strengthens immunity. Chitosan that prevents bacterial growth. However, there was a pit in a place where they believed and believed that "they inhibit the growth of general bacteria but have little effect on useful bacteria such as lactic acid bacteria." It is a chitosan that inhibits the growth of pathogenic and non-pathogenic bacteria such as Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus. Under conditions below the borderline, even useful bacteria in the brain, such as bifidobacteria, are prevented from growing and decrease, and it is only natural that the intestinal environment deteriorates.

【0010】本発明は、脂質消化吸収阻害作用があるキ
トサンの、或る条件下に発生するマイナス面の便性不良
の改善および健康への相乗性のため、ビフィズス菌ない
し腸内有用菌類の混合物を有効成分として含有するこ
と、を特徴とするものである。
[0010] The present invention relates to a mixture of bifidobacteria or useful enteric fungi, in order to improve the disadvantageous inconvenience and the synergistic effect of health of chitosan having an effect of inhibiting lipid digestion and absorption under certain conditions. Is contained as an active ingredient.

【0011】[0011]

【発明の実施の形態】本発明の実施においてキトサンは
焼津水産化学工業株式会社、ビフィズス菌は明治乳業株
式会社の生菌を使用した。より効果を高めるために植物
性のオオバコおよびリンゴファイバーを加え、オリゴ
糖:明治製糖株式会社のラフィノースをプラス、全て体
に優しい天然成分で構成した。
BEST MODE FOR CARRYING OUT THE INVENTION In the practice of the present invention, chitosan used was Yaizu Suisan Kagaku Kogyo Co., Ltd., and bifidobacterium used was Meiji Dairy Co., Ltd. To enhance the effect, vegetable psyllium and apple fiber were added, and oligosaccharides: Raffinose from Meiji Sugar Co., Ltd. were added, and all were composed of natural ingredients that were kind to the body.

【0012】[0012]

【発明の効果】本発明は以上のように構成されているの
で、以下に記載されるような効果を奏する。
Since the present invention is configured as described above, it has the following effects.

【0013】ビフィズス生菌はビィズス菌を直接補給す
る。植物性オオバコおよびリンゴファイバーはビフィズ
ス菌の胃酸による減少を抑制し生菌を包括して生きたま
ま腸まで届け、満腹感で食欲を抑制し、脂肪分や糖分を
吸着し、便量を増やし、腸内環境を整えるのに役立つ。
オリゴ糖は腸内におけるビフィズス菌等の直接な餌とな
り有用菌の増殖に大変有効である。
The live Bifidobacterium directly supplies the Bifidobacterium. Vegetable psyllium and apple fiber suppress the decrease of bifidobacteria due to stomach acid, enclose living bacteria and deliver them to the intestine alive, suppress appetite with satiety, adsorb fat and sugar, increase stool volume, Helps to maintain intestinal environment.
Oligosaccharides serve as a direct feed for bifidobacteria and the like in the intestine, and are very effective in growing useful bacteria.

【0014】便性の改善は著しかった。便秘の解消。ベ
タ便の改善。心地よい便通。形良い黄色便で水に浮き、
臭みが減った。僅か一週間の結果である。
The improvement in convenience was remarkable. Relief of constipation. Improvement of solid stool. Comfortable bowels. Floating in the water with a good yellow stool,
The smell has been reduced. The result is only one week.

【0015】その他、顔のくすみや、吹き出もの、顔
色、頭痛、体臭の減少、睡眠、目覚めの良さ、体調が良
くなる等々の好転が見られた。腸は食べた栄養を吸収し
体を作る大元である。隅の有用菌特にビフィズス菌は加
齢とともに減少、添加物、薬物、肉食、油脂、煙草、ア
ルコール等によっても減少しO−157等に見るような
免疫不全、体力衰弱等を起こしやすくなる。嫌なことが
あると胃やお腹が痛むように、その時ビフィズス菌は激
減し、消化も栄養吸収も出来なくなる。ストレスは体に
極めて悪い。消化吸収力低下で体力の減退が起きると生
命そのものまでがおびやかされる。腸の健康、すなはち
腸内菌のバランスこそ生命の全てである。
In addition, improvement such as dullness of the face, puffiness, complexion, headache, decrease in body odor, sleep, good awakening, and improvement in physical condition were observed. The intestine is the source of the body that absorbs the nutrients it eats and builds its body. The useful bacteria in the corner, especially the bifidobacteria, decrease with aging, and also decrease due to additives, drugs, carnivores, oils and fats, tobacco, alcohol, etc., and are liable to cause immunodeficiency, physical weakness and the like as shown in O-157 and the like. Just as the stomach and stomach hurts when things are bad, the bifidobacteria are then drastically reduced, making it impossible to digest or absorb nutrients. Stress is extremely bad for the body. If physical strength declines due to reduced digestive absorption, even life itself is threatened. Intestinal health, that is, the balance of intestinal bacteria, is all about life.

【0016】高齢者や体力低下の人、ストレスのある人
は共通してビフィズス菌を始めとする有用菌が若い人、
健康な人より確実に少ないことが証明されている。そう
いう人がキトサンを多摂取すると脂質消化吸収抑制のプ
ラス面より腸内有用菌の減少で体調が乱されることにな
る。悪玉菌の代表・腐敗菌と呼ばれるウェルシュ菌・大
腸菌はアンモニアやアミン、硫化水素といった有害菌を
つくりだす。発ガン物質だけでなく老化原因物質もつく
りだす。キトサン摂取による脂質消化吸収抑制は腸の健
康が保たれてこそ生かされる。ビフィズス菌の補給およ
びその増殖環境づくりは、キトサン効果や若さを保つの
に重要不可欠である。
Elderly people, people with low physical strength, and stressed people commonly have young useful bacteria such as bifidobacteria,
Proven to be definitely less than healthy people. If such a person consumes a large amount of chitosan, the physical condition will be disturbed due to a decrease in useful intestinal bacteria, rather than the suppression of lipid digestion and absorption. Welsh bacteria and Escherichia coli, which are representatives of bad bacteria and are called spoilage bacteria, produce harmful bacteria such as ammonia, amines, and hydrogen sulfide. It produces not only carcinogens but also aging agents. Inhibition of lipid digestion and absorption by ingestion of chitosan can only be used if gut health is maintained. Supplementation of the bifidobacterium and creation of an environment for its growth are essential for maintaining the chitosan effect and youth.

【0017】[0017]

【実施例】ビフィズス生菌の保存性の点から顆粒仕上げ
でアルミスティックに封入、水等に溶いて飲むジュース
タイプにした。1日2回で必要な量を摂取できるように
し人、体質、時によって自由に調整できる巾を持たせ
た。キトサンは「脂質消化吸収抑制」と味覚における
「えぐ味」および「有用菌の成育阻止」等のバランスか
ら1袋1000mgとした。ビフィズス菌は胃酸に強い
ビフィズス菌の開発者である光岡知足東京大学教授の指
導に従い、生きたまま賜まで届く経口量100億個を目
安に1袋50億個とした。オリゴ糖、食物繊維の他、飲
みやすくするために爽やかな柑橘風味に仕立てた。1袋
6gを約180mlの水で溶いて飲用する。
EXAMPLE From the viewpoint of preservation of viable Bifidobacteria, a juice type was prepared which was encapsulated in an aluminum stick with granule finish and dissolved in water or the like. The required amount can be taken twice a day, and the width can be freely adjusted depending on the person, constitution and time. Chitosan was used in an amount of 1000 mg per bag in consideration of the balance between “suppression of lipid digestion and absorption” and “taste” and “inhibition of growth of useful bacteria” in taste. According to the guidance of the professor of the University of Tokyo, Tomotsu Mitsuoka, a bifidobacterium-resistant bifidobacterium developer, the number of oral births was set at 5 billion per bag, based on a 10-billion oral dose that could reach alive. In addition to oligosaccharides and dietary fiber, it was made with a refreshing citrus flavor to make it easier to drink. Dissolve 6 g per bag with about 180 ml of water and drink.

【0018】表1記載のスティックを32人に1日2
袋、1週間モニタリングした。対象は20〜50歳代の
女性。A:20歳代、B:30歳代、C:40歳代、
D:50歳代。摂取方法は朝夕食後に1袋ずつ。被験者
はすべて便秘で悩む女性である。
The sticks described in Table 1 were given to 32 persons 2 times a day.
Bags were monitored for one week. The subjects are women in their 20s and 50s. A: 20s, B: 30s, C: 40s,
D: 50s. Take 1 bag after breakfast and dinner. All subjects are women who suffer from constipation.

【0019】表2の記載に見るように、便秘症状の改善
効果は極めて素晴らしい。脂質消化吸収抑制しながら腸
の環境を整え、しかも一切の副作用も見られない。24
以降の効果が出にくい傾向の人は、かなり強い便秘薬の
常習者であり下剤による刺激慣れから腸環境の正常化ま
で時間を要する。30の人、嗜好的な点で飲用を好まな
い人には、味を変えることにより解決できる。本発明に
よる脂質吸収阻害整腸剤は、その構成が天然の素材であ
り、継続することにより100%近い人の症状改善やキ
トサン摂取による不良便性化を防ぐことができる。
As shown in Table 2, the effect of improving constipation symptoms is extremely excellent. Prepares intestinal environment while suppressing lipid digestion and absorption, and shows no side effects. 24
Those who tend to have little effect after that are addicts of a very strong constipation drug, and it takes time from accustomed to stimulation with laxatives to normalization of the intestinal environment. For 30 people who do not like drinking in terms of taste, this can be solved by changing the taste. The lipid absorption inhibiting intestinal preparation according to the present invention is composed of a natural material, and by continuing it, it is possible to improve symptoms of almost 100% of humans and prevent inconvenience caused by ingestion of chitosan.

【0020】サイレントな動脈硬化、生活習慣病を予防
し若々しい健康で長寿であるためには、先ず賜を整え、
サラサラした奇麗な血液をつくることが大切である。ム
リなダイエットをしている人、お年寄りや入院患者、ス
トレス環境や喫煙、暴飲暴食、薬物や添加物等にさらさ
れる現代人は脂質や糖の吸収抑制、便通の改善は急務で
ある。キトサンにプラスして、腸内の有害菌の増殖を抑
え、ビタミンを合成したり、消化吸収を助け健康に大事
な働きをしているエース格のビフィズス菌ないし有用菌
類を同時に補給し、生きたまま腸まで届く環境づくりの
ため植物性食物繊維や餌となるオリゴ糖類のトリプルサ
ポートは人類にとって最も原始的、旧くて新しい、自然
で優しい健康法である。
In order to prevent silent arteriosclerosis and lifestyle-related diseases and achieve youthful health and longevity,
It is important to make clean and smooth blood. It is urgent for people on a slim diet, the elderly and hospitalized patients, modern people who are exposed to stressful environments, smoking, binge eating, drugs and additives, etc. to suppress lipid and sugar absorption and improve bowel movements. In addition to chitosan, it suppresses the growth of harmful bacteria in the intestine, synthesizes vitamins, assists in digestion and absorption, and at the same time replenishes ace grade bifidobacteria or useful fungi that play an important role in health, Triple support of plant dietary fiber and dietary oligosaccharides is the most primitive, old and new, natural and gentle health method for human beings to create an environment that can reach the intestine as it is.

【表 1】 [Table 1]

【表 2】 [Table 2]

【表 3】 [Table 3]

─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成10年2月12日[Submission date] February 12, 1998

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】特許請求の範囲[Correction target item name] Claims

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【特許請求の範囲】[Claims]

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 キトサンとビフィズス菌ないし腸内有用
菌類との混合物を有効成分として含有することを特徴と
する、脂質消化吸収阻害整腸剤。
1. An intestinal preparation for inhibiting lipid digestion and absorption, comprising a mixture of chitosan and bifidobacteria or useful enteric fungi as an active ingredient.
JP9149819A 1997-05-06 1997-05-06 Drug for controlling intestinal function by lipid digestive absorbent inhibition Pending JPH10306028A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9149819A JPH10306028A (en) 1997-05-06 1997-05-06 Drug for controlling intestinal function by lipid digestive absorbent inhibition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9149819A JPH10306028A (en) 1997-05-06 1997-05-06 Drug for controlling intestinal function by lipid digestive absorbent inhibition

Publications (1)

Publication Number Publication Date
JPH10306028A true JPH10306028A (en) 1998-11-17

Family

ID=15483402

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9149819A Pending JPH10306028A (en) 1997-05-06 1997-05-06 Drug for controlling intestinal function by lipid digestive absorbent inhibition

Country Status (1)

Country Link
JP (1) JPH10306028A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036075A1 (en) * 1998-01-17 1999-07-22 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Oral oil sorbing composition
JP2000327569A (en) * 1999-05-20 2000-11-28 Nippon Taanaa Kk Intraintestinal environment ameliorator
JP2002509891A (en) * 1998-04-01 2002-04-02 ガネデン バイオテック, インコーポレイテッド Methods, systems, and compositions for reducing cholesterol using Bacilluscoagulans spores
KR20030069231A (en) * 2002-02-02 2003-08-27 비앤아이티(주) The improvement product of intestianl function by means of constipation type
KR20030096615A (en) * 2002-06-17 2003-12-31 방성모 A composite and manufacture method distinguished constipation improvement effect
WO2012076739A1 (en) 2010-12-07 2012-06-14 Consejo Superior De Investigaciones Científicas C.S.I.C. Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies
US9446111B2 (en) 2009-04-29 2016-09-20 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036075A1 (en) * 1998-01-17 1999-07-22 West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited Oral oil sorbing composition
JP2002509891A (en) * 1998-04-01 2002-04-02 ガネデン バイオテック, インコーポレイテッド Methods, systems, and compositions for reducing cholesterol using Bacilluscoagulans spores
JP2000327569A (en) * 1999-05-20 2000-11-28 Nippon Taanaa Kk Intraintestinal environment ameliorator
KR20030069231A (en) * 2002-02-02 2003-08-27 비앤아이티(주) The improvement product of intestianl function by means of constipation type
KR20030096615A (en) * 2002-06-17 2003-12-31 방성모 A composite and manufacture method distinguished constipation improvement effect
US9446111B2 (en) 2009-04-29 2016-09-20 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US9757442B2 (en) 2009-04-29 2017-09-12 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
WO2012076739A1 (en) 2010-12-07 2012-06-14 Consejo Superior De Investigaciones Científicas C.S.I.C. Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of excess weight, obesity and related pathologies
US11235008B2 (en) 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US11351206B2 (en) 2011-03-31 2022-06-07 Ganeden Biotech, Inc. Probiotic sports nutrition compositions

Similar Documents

Publication Publication Date Title
CA2878005C (en) Composition and use of a formulation to increase the ratio of gastrointestinal microbiota in phylum bacteriodetes to microbiota of firmicutes phylum
JP4955896B2 (en) Nutritional composition
JP2013146281A (en) Dietary supplement
US20140017337A1 (en) Therapeutic methods
JP2010162040A (en) Dietary supplement food and method of treating digestive system-related trouble
JPH05255097A (en) Liquid composition
JPH10306028A (en) Drug for controlling intestinal function by lipid digestive absorbent inhibition
US20190373939A1 (en) Methods of Making a Bigger Volume of Foods for Weight Control
US20060210606A1 (en) Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood
JP2004329047A (en) Dietary supplement
Swartz et al. How to Heal Hemorrhoid Pain Permanently!: What are Hemorrhoids? What Causes Hemorrhoid Pain? How to Get Relief Now. When to See a Doctor. Five Powerful Strategies to Heal Hemorrhoid Pain Forever.
Honda Reverse Gut Diseases Naturally: Cures for Crohn's Disease, Ulcerative Colitis, Celiac Disease, IBS, and More
Onokayeigho Older Adults and Health Maintenance (1)
Myers Symptoms of Diseases
Shelton et al. Solutions to Diabetes and Hypoglycemia (Translated): How to prevent and get rid of it in a natural way, without resorting to medicines but adopting a correct way of life
Greber Chronic Digestive Disorders
JP2023517400A (en) Beverage composition and method of forming same
Dalvi Adrenal Fatigue, a Desk Reference
RU2434627C1 (en) Method of correcting body weight gain after giving up smoking
Lam The Latest on Body Cleansing and Detoxification
Khan 8 Home Remedies to Improve Loss of Appetite
Rose et al. Save Your Sight!: Natural Ways to Prevent and Reverse Macular Degeneration
Hutchens Total Cleansing: Learn the Secrets for Effective Detox
Peshek Searching for Health
Sharma Herbal home remedies